Funding for this research was provided by:
Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (20H03941)
Article History
Received: 24 May 2021
Revised: 4 August 2021
Accepted: 16 August 2021
First Online: 9 September 2021
Declarations
:
: This study was approved by the Institutional Review Board at Kyoto University. We performed this study in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This study did not need individual consent because the data were anonymized.
: Koji Kawakami has received research funds from Eisai Co. Ltd.; Kyowa Kirin Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Pfizer Inc.; Stella Pharma Corporation; CMIC Co. Ltd.; Suntory Beverage & Food Ltd.; Mitsubishi Corporation, and Real World Data Co. Ltd.; consulting fees from LEBER Inc.; JMDC Inc.; Shin Nippon Biomedical Laboratories Ltd.; Kaken Pharmaceutical Co. Ltd.; and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems; Inc.; honorarium from Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, and Pharma Business Academy; and holds stock in Real World Data Co. Ltd. Other authors declare no competing interests.